AI assistant
JOHNSON & JOHNSON — Director's Dealing 2020
Jul 29, 2020
29750_dirs_2020-07-28_09cc248a-9859-42f1-b974-5437ba35d9d2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2020-07-28
Reporting Person: McEvoy Ashley (EVP, WW Chair, Medical Devices)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-28 | Common Stock | S | 29000.0000 | $147.4700 | Disposed | 21681.5018 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2451.0000 | Indirect |
| Common Stock | 300.0000 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $147.33 to $147.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2020).
F3: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2020).